Industry News
Fish learn to cope in high CO2 world
Some coral reef fish may be better prepared to cope with rising CO2 in the world’s oceans - thanks to their parents. Researchers at the ARC Centre of Excellence for Coral Reef Studies (CoECRS) have reported encouraging new findings that some fish may be less vulnerable to high CO2 and an acidifying ocean than previously feared. [ + ]
DNA sequenced for parrot’s ability to parrot
Scientists say they have assembled more completely the string of genetic letters that could control how well parrots learn to imitate their owners and other sounds. [ + ]
Feature: Jill Banfield, extremophile
Geomicrobiology, environmental biogeochemistry, mineralogy, nanogeoscience, metagenomics, microbial community ecology and evolution. These are but some of the research interests of Professor Jill Banfield. [ + ]
CBio to merge with Inverseon
Brisbane's CBio (ASX:CBZ) plans to merge with US-based Inveseon to create new inflammatory disease focused biotech, Invion. [ + ]
pSivida enrols first patient for uveitis trial
pSivida (ASX:PVA) has signed up the first patient for an investigator-sponsored trial of its inserts and ILUVIEN drug in eye disease posterior uveitis. [ + ]
Phosphagenics enters horse supplement tie-up
Phosphagenics (ASX:POH) and Equine Nutrition Australia will collaborate to create equine nutritional supplements using the former's TPM technology. [ + ]
Positive at last: a pure phosphorus cation
A research team led by Prof Dr Ingo Krossing from the Faculty of Chemistry, Pharmacy, and Earth Sciences of the University of Freiburg has now succeeded in creating a positively charged pure phosphorus compound. [ + ]
Automated system to detect infectious diseases for Olympics 2012
The world’s first comprehensive, automated outbreak detection system will monitor over 3000 infections and is ready to run during the 2012 Olympics. [ + ]
Bioxyne's COPD clinical trial disappoints
Shares in Bioxyne (ASX:BSN) sank 82% on Thursday, after the company revealed a trial of HI 164 OV showed clinical benefit only in COPD patients younger than 65. [ + ]
Victorian Government opens ‘Investing in Manufacturing Technology’ Grants
Grants of up to $250,000 are available under the Investing in Manufacturing Technology (IMT) grants scheme to assist businesses to purchase and integrate new technologies into their business. [ + ]
Stable antibody breakthrough solves sticky biotech problem
Researchers at the Garvan Institute have developed a new technique to produce antibodies that are resistant to clinging together into a sticky mess, solving a longstanding technical problem in biotech. [ + ]
Bell Potter downgrades QRxPharma after FDA shock
Bell Potter Securities has reset its optimistic target valuation of QRxPharma from $3.69 to $1.26 after the FDA failed to approve the company’s MoxDuo IR. [ + ]
BioDiem licenses hepatitis vaccine tech from UC
BioDiem (ASX:BDM) has signed its second vaccine technology licensing deal this week, securing exclusive rights to IP with potential applications in hepatitis B and D. [ + ]
QRxPharma shares tumble after FDA knockback for MoxDuo IR
Shares down over 50% after the FDA requests more information on safety and efficacy from QRxPharma on its MoxDuo IR before granting regulatory approval. [ + ]
Free app makes it easier to work with technical gases
As anyone who works with them will tell you, it is impossible to know everything about technical gases off by heart. But now there is no need to: iGASES, the new app from Witt for iPhone, iPad and Android devices, answers your questions, even interactively. [ + ]
